相关实验视频

Updated: Jan 15, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

在患有心房的患者中,在 Carotid 支架后的二次预防

Alex D Hanson¹, Diedo J Ojeda², Arshaq Saleem³

¹Department of Neurology, University of Iowa, Iowa City, IA, USA.

Vascular and endovascular surgery

|October 16, 2025

概括

在动脉支架 (CAS) 后心房的患者中,在双抗血小板治疗 (DAPT),单抗血小板治疗加抗凝血 (AA) 或三重治疗 (TT) 之间,在出血或中风风险方面没有发现显著差异. 这项研究比较了这些疗法的长期疗效和安全性.

科学领域:

心脏病学心脏病学
神经学神经学
血管外科血管外科

背景情况:

在心房的患者中,在 carotid 动脉支架 (CAS) 后进行最佳的二次中风预防缺乏共识.
现有的治疗策略涉及抗血小板和抗凝固药物治疗的各种组合.
了解这些治疗方案的比较疗效和安全性对于临床决策至关重要.

研究的目的:

为了比较不同医疗方案的长期疗效和安全性,在患有心房的患者中遵循CAS.
评估结果,包括大出血,小出血,复发性中风和支架血栓形成.

主要方法:

追溯观察性研究包括129名心房患者在2011年至2024年期间接受CAS.
患者被分为三组:双抗血小板治疗 (DAPT),单抗血小板治疗加口服抗凝药 (AA) 和三重治疗 (TT).
主要结局是严重出血;次要结局包括轻微出血,复发性中风和支架血栓形成.

主要成果:

在DAPT (3.2%),AA (6.5%) 和TT (7.7%) 组 (P = 0.71) 中,在3个月后主要出血事件中没有发现显著差异.
支架放置后缺血性中风的发生率相似:DAPT (6.4%),AA (4.3%) 和TT (1.9%) (P = 0.57).
支架血栓发生率也没有显著变化:DAPT (3.2%),AA (6.5%) 和TT (1.9%) (P = 0.32).

结论:

研究结果表明,DAPT,AA和TT治疗方案的长期安全性和有效性在CAS后心房患者的二次中风预防方面相似.
需要进一步的前性研究来证实这些观察,并完善治疗指南.

关键词:

抗血栓药物是一种抗血栓药物.动脉样硬化动脉样硬化动脉动脉疾病动脉动脉疾病二次预防二次预防.一次性中风中风中风中风中风

更多相关视频

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

相关概念视频

Atherosclerosis IV: Nursing Management

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Acute Coronary Syndrome IV: Interprofessional Care

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

Aortic Regurgitation III: Medical Management

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...